Why the study?
Is pregnancy safe in patients with hypertrophic cardiomyopathy, and what are the effects of beta-adrenergic blocking drugs on fetal outcomes?
Population
23 pregnant patients with hypertrophic cardiomyopathy (accounting for 54 pregnancies)
Comparison
Beta-adrenergic blocking drugs vs No beta-adrenergic blocking drugs
Design
Cohort
Follow-up
Perinatal period
Authors
Loading...
Warrants fetal monitoring with beta-blockers in HCM pregnancies; leaves open optimal management pending larger prospective studies.
Is pregnancy safe in patients with hypertrophic cardiomyopathy, and what are the effects of beta-adrenergic blocking drugs on fetal outcomes?
Pregnancy is generally safe in patients with hypertrophic cardiomyopathy, but beta-blockers should be used cautiously due to potential fetal risks such as bradycardia and small-for-dates babies.
Oakley et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: